Autoantibodies against type I IFNs in patients with life-threatening COVID-19
暂无分享,去创建一个
Steven M. Holland | Amelia Licari | Gian Luigi Marseglia | Alessandro Aiuti | Guillaume Vogt | Eystein S. Husebye | Xavier Duval | Charles M. Rice | Paolo Bonfanti | Lluis Quintana-Murci | John S. Tsang | Patrick Rossignol | Petter Brodin | Giorgio Casari | Michel C. Nussenzweig | Andrew J. Oler | Benedetta Bigio | Yoann Seeleuthner | Gaspard Kerner | Jérémie Rosain | Laurent Abel | Darragh Duffy | András N. Spaan | Stéphanie Boisson-Dupuis | Kerry Dobbs | Luigi D. Notarangelo | Kai Kisand | Pärt Peterson | Andrea Biondi | Stuart G. Tangye | Shen-Ying Zhang | Jingwen Gu | Peter D. Burbelo | Aurélie Cobat | Diederik van de Beek | Riccardo Castagnoli | F. Rieux-Laucat | J. Casanova | C. Rice | M. Nussenzweig | F. Fusco | L. Notarangelo | S. Holland | S. Tangye | K. Dobbs | J. Martinez-Picado | R. Lifton | J. Tsang | K. Bilguvar | Shen-Ying Zhang | P. Peterson | L. Quintana-Murci | B. Bigio | L. Abel | Lindsey B. Rosen | D. Vinh | A. Licari | G. Marseglia | P. Rossignol | D. Duffy | A. Bolze | A. Puel | J. Cohen | J. Manry | Camillo Rossi | H. Hoffmann | G. Casari | J. Hadjadj | F. Haerynck | A. Belot | L. Piemonti | T. Mogensen | L. Roussel | E. Jouanguy | H. Su | M. Ursini | E. Husebye | A. Aiuti | P. Brodin | Y. Seeleuthner | F. Ciceri | D. Montagna | P. Bastard | L. Lorenzo | P. Burbelo | M. Lionakis | A. Biondi | D. van de Beek | E. Michailidis | R. Goldbach-Mansky | S. Boisson-Dupuis | L. Bettini | P. Bonfanti | C. Rodríguez-Gallego | D. Smadja | V. Béziat | É. Catherinot | L. Imberti | Qian Zhang | M. Migaud | B. Terrier | G. Vogt | Jade Ghosn | Jean-Laurent Casanova | E. Quiros-Roldan | J. Rosain | Q. Philippot | E. Shaw | K. Kisand | M. Abers | X. Duval | A. Cobat | A. Sottini | Guy Gorochov | Karim Dorgham | Lorenzo Piemonti | Vito Lampasona | Javier Martinez-Picado | Eugenia Quiros-Roldan | David Dalmau | Fabio Ciceri | Daniela Montagna | G. Gorochov | Kaya Bilguvar | Richard P. Lifton | R. Castagnoli | J. Mayaux | M. Vasse | Anne Puel | Raphaela Goldbach-Mansky | Carlos Rodríguez-Gallego | Ottavia M. Delmonte | Alexandre Bolze | Julien Mayaux | Alessandra Sottini | Luisa Imberti | Vivien Béziat | Benjamin Terrier | K. Dorgham | Emmanuelle Jouanguy | Qian Zhang | Paul Bastard | Rui Yang | Yu Zhang | Quentin Philippot | Hans-Heinrich Hoffmann | Eleftherios Michailidis | Lazaro Lorenzo | Lucy Bizien | Lucie Roussel | Laura Rachele Bettini | Simone Paghera | Camillo Rossi | Filomeen Haerynck | Yacine Tandjaoui-Lambiotte | Donald C. Vinh | Trine H. Mogensen | Helen C. Su | V. Lampasona | O. Delmonte | Jérémy Manry | Elana Shaw | Liis Haljasmägi | Sophie Trouillet-Assant | Adriana Almeida de Jesus | Alexandre Belot | Anne Kallaste | Emilie Catherinot | Jeremie Le Pen | Michael S. Abers | Marc Vasse | David M. Smadja | Mélanie Migaud | Jérome Hadjadj | Jeffrey I. Cohen | Mariella D'Angio | Frédéric Rieux-Laucat | Francesca Fusco | Matilde Valeria Ursini | Michail S. Lionakis | Gaspard Kerner | D. Dalmau | A. Spaan | J. Ghosn | Jingwen Gu | S. Trouillet-Assant | A. Kallaste | Jérémie Le Pen | Y. Tandjaoui-Lambiotte | A. D. de Jesus | Rui Yang | Yu Zhang | S. Paghera | L. Haljasmägi | L. Bizien | M. D'Angiò | Lucie Roussel | J. Le Pen | Jingwen Gu | Lazaro Lorenzo | Hans-Heinrich Hoffmann | Benedetta Bigio | Jérémie Rosain
[1] F. Zannad,et al. Cohort Profile: Rationale and design of the fourth visit of the STANISLAS cohort: a familial longitudinal population-based cohort from the Nancy region of France. , 2018, International journal of epidemiology.
[2] F. Cetani,et al. Abbreviations used: AD, , 2022 .
[3] J. Lindenmann,et al. Virus interference. I. The interferon , 1957, Proceedings of the Royal Society of London. Series B - Biological Sciences.
[4] I. Gresser,et al. Wherefore interferon? , 1997, Journal of leukocyte biology.
[5] Harnish Mukesh Naik,et al. Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population. , 2020, The Journal of clinical investigation.
[6] David M. Rissin,et al. Single-Molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations , 2010, Nature Biotechnology.
[7] J. Casanova,et al. Recurrent Staphylococcal Cellulitis and Subcutaneous Abscesses in a Child with Autoantibodies against IL-61 , 2008, The Journal of Immunology.
[8] K. Katoh,et al. MAFFT version 5: improvement in accuracy of multiple sequence alignment , 2005, Nucleic acids research.
[9] Sergei L. Kosakovsky Pond,et al. Evolution of the interferon alpha gene family in eutherian mammals. , 2007, Gene.
[10] J. Casanova,et al. Evolutionary genetic dissection of human interferons , 2011, The Journal of experimental medicine.
[11] J. Ravetch,et al. Functional diversification of IgGs through Fc glycosylation. , 2019, The Journal of clinical investigation.
[12] J. Casanova,et al. The human genetic determinism of life-threatening infectious diseases: genetic heterogeneity and physiological homogeneity? , 2020, Human Genetics.
[13] K. Wasunna. Drugs for Neglected Diseases Initiative. , 2005, African journal of health sciences.
[14] I. Gresser,et al. Characteristics of autoantibodies to human interferon in a patient with varicella-zoster disease. , 1984, The Journal of infectious diseases.
[15] R. Davey,et al. Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019 , 2020, The Journal of Infectious Diseases.
[16] J. Darnell. STATs and gene regulation. , 1997, Science.
[17] J. Vilček,et al. Antibodies to alpha-interferon in a patient with systemic lupus erythematosus. , 1982, Journal of immunology.
[18] U. Göbel,et al. Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans. , 2004, Blood.
[19] Jacques Fellay,et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 , 2020, Science.
[20] J. Vivian,et al. Structural integrity with functional plasticity: what type I IFN receptor polymorphisms reveal , 2020, Journal of leukocyte biology.
[21] Kazutaka Katoh,et al. MAFFT online service: multiple sequence alignment, interactive sequence choice and visualization , 2017, Briefings Bioinform..
[22] Nicolas Carlier,et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients , 2020, Science.
[23] J. B. Oliveira,et al. Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency. , 2015, The Journal of clinical investigation.
[24] C. Rice,et al. Interferons and viruses: an evolutionary arms race of molecular interactions. , 2015, Trends in immunology.
[25] K. Brengel-Pesce,et al. Type I IFN immunoprofiling in COVID-19 patients , 2020, Journal of Allergy and Clinical Immunology.
[26] C. D. Krause,et al. Interferons, interferon‐like cytokines, and their receptors , 2004, Immunological reviews.
[27] Hedi Peterson,et al. AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating Autoantibodies , 2016, Cell.
[28] R. Valentine,et al. Virus interference. II. Some properties of interferon , 1957, Proceedings of the Royal Society of London. Series B - Biological Sciences.
[29] J. Aicardi,et al. Early intrathecal synthesis of interferon in herpes encephalitis. , 1979, Biomedicine / [publiee pour l'A.A.I.C.I.G.].
[30] P. Peterson,et al. Anti-Interferon Autoantibodies in Autoimmune Polyendocrinopathy Syndrome Type 1 , 2006, PLoS medicine.
[31] Rainer Döffinger,et al. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[32] N. Saitou,et al. The neighbor-joining method: a new method for reconstructing phylogenetic trees. , 1987, Molecular biology and evolution.
[33] H. von Bernuth,et al. Autoantibodies against cytokines: phenocopies of primary immunodeficiencies? , 2020, Human Genetics.
[34] J. Bach. Organ-specific autoimmunity. , 1995, Immunology series.
[35] D. Relman,et al. Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma. , 2005, The Journal of clinical investigation.
[36] R. Schwartz,et al. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 , 2020, Cell.
[37] G. Iotti,et al. A COVID-19 pneumonia case report of autoimmune polyendocrine syndrome type 1 in Lombardy, Italy: letter to the editor , 2020, Journal of Endocrinological Investigation.
[38] Y. Rotman,et al. Development of a Validated Interferon Score Using NanoString Technology. , 2018, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[39] J. Casanova. Ion Gresser. , 2019, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[40] C. Rice,et al. Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals , 2020, Nature.
[41] A. Fischer,et al. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I , 2010, The Journal of experimental medicine.
[42] Christian M. Zmasek,et al. phyloXML: XML for evolutionary biology and comparative genomics , 2009, BMC Bioinformatics.
[43] C. Cole,et al. X inactivation as a mechanism of selection against lethal alleles: further investigation of incontinentia pigmenti and X linked lymphoproliferative disease. , 1992, Journal of medical genetics.
[44] F. Rieux-Laucat,et al. Monitoring Disease Activity in Systemic Lupus Erythematosus With Single‐Molecule Array Digital Enzyme‐Linked Immunosorbent Assay Quantification of Serum Interferon‐α , 2019, Arthritis & rheumatology.
[45] Jacques Fellay,et al. A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection , 2020, Cell.
[46] William R. Taylor,et al. The rapid generation of mutation data matrices from protein sequences , 1992, Comput. Appl. Biosci..
[47] D. Niethammer,et al. Interferon-neutralizing antibodies in a patient treated with human fibroblast interferon , 1981, Nature.